Targeted Therapeutic Drug Monitoring (TDM) for Direct Oral Anticoagulants (DOACs)- What Is Its Potential Place and Can It Limit Black Swan Events?
Canadian Journal of Cardiology - Canada
doi 10.1016/j.cjca.2018.08.006
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Elsevier BV